CD38 and COVID-19: We next determined the activation status of CD4+ and CD8+ T cells (Figures 2F–H) and observed that patients with moderate and severe COVID-19 show increased accumulation of activated HLA-DR+CD38+CD8+ T cells, which distinguished these cohorts from healthy controls and convalescent individuals (Figures 2F–H).